LPL Financial’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.27M | Sell |
14,121
-16,701
| -54% | -$5.05M | ﹤0.01% | 2434 |
|
|
2025
Q1 | $10.2M | Buy |
30,822
+25,602
| +490% | +$8.48M | ﹤0.01% | 1586 |
|
|
2024
Q4 | $1.61M | Buy |
5,220
+480
| +10% | +$148K | ﹤0.01% | 3048 |
|
|
2024
Q3 | $1.01M | Sell |
4,740
-438
| -8% | -$93K | ﹤0.01% | 3351 |
|
|
2024
Q2 | $1.45M | Buy |
5,178
+1,749
| +51% | +$490K | ﹤0.01% | 2876 |
|
|
2024
Q1 | $916K | Sell |
3,429
-143
| -4% | -$38.2K | ﹤0.01% | 3230 |
|
|
2023
Q4 | $826K | Buy |
+3,572
| New | +$826K | ﹤0.01% | 3187 |
|
|
2023
Q3 | – | Sell |
-1,010
| Closed | -$233K | – | 4685 |
|
|
2023
Q2 | $233K | Buy |
1,010
+184
| +22% | +$42.5K | ﹤0.01% | 3993 |
|
|
2023
Q1 | $200K | Sell |
826
-57
| -6% | -$13.8K | ﹤0.01% | 4020 |
|
|
2022
Q4 | $256K | Buy |
+883
| New | +$256K | ﹤0.01% | 3769 |
|
|
2022
Q2 | – | Sell |
-3,768
| Closed | -$370K | – | 4460 |
|
|
2022
Q1 | $370K | Buy |
+3,768
| New | +$370K | ﹤0.01% | 3401 |
|
|
2021
Q4 | – | Sell |
-2,813
| Closed | -$224K | – | 4390 |
|
|
2021
Q3 | $224K | Sell |
2,813
-205
| -7% | -$16.3K | ﹤0.01% | 3856 |
|
|
2021
Q2 | $294K | Buy |
3,018
+675
| +29% | +$65.8K | ﹤0.01% | 3590 |
|
|
2021
Q1 | $274K | Buy |
+2,343
| New | +$274K | ﹤0.01% | 3527 |
|
|
2019
Q1 | – | Sell |
-2,260
| Closed | -$255K | – | 3200 |
|
|
2018
Q4 | $255K | Buy |
2,260
+947
| +72% | +$107K | ﹤0.01% | 2579 |
|
|
2018
Q3 | $281K | Sell |
1,313
-10
| -0.8% | -$2.14K | ﹤0.01% | 2743 |
|
|
2018
Q2 | $370K | Buy |
+1,323
| New | +$370K | ﹤0.01% | 2443 |
|